NYK MEDICS LIMITEDActive

Company number 09661577Private limited companyIncorporated 2015

Key figures

£148,778-0.3%
Net assets 2024/25
+187.2%
Average annual growth 2019/20–2024/25
050 k100 k150 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, NYK MEDICS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand142,2113,5331,30297,31936,560
Total assets145,012153,137167,434232,537169,814
Total liabilities120,25278,96051,35683,24821,036
Net assets / total equity28,06674,177116,078149,289148,778
Average number of employees11110

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

86102

As described in the company's latest filed accounts.

Summary: NYK MEDICS LIMITED

Company

NYK MEDICS LIMITED is a private limited company registered with Companies House under company number 09661577. It was incorporated on 29 Jun 2015. Its status is active. The registered office is in Ilford (IG3). Its nature of business (SIC 2007) is medical nursing home activities (86102).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 May 2025); the company files small company accounts (filleted). Net assets were £148,778, down 0.3% on the previous year. Cash at bank and in hand was £36,560. Total assets were £169,814 and total liabilities £21,036. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 28 Feb 2027. The next confirmation statement is due by 13 Jul 2027.